Amendment ID: S2397-7

Amendment 7

Technical clarification related to academic detailing

Mr. Lewis moves that the proposed new draft be amended in Section 15A of SECTION 18 by striking subsection (e) and inserting in place thereof the following:-

(e) The commission shall assess pharmaceutical and biopharmaceutical manufacturing companies and pharmacy benefit managers for estimated expenses related to this section pursuant to section 6. The commission may establish and collect fees for subscriptions and contracts with private health care payers related to this section. The commission may seek funding from nongovernmental health access foundations and undesignated drug litigation settlement funds associated with pharmaceutical marketing and pricing practices.